Showing results (1211-1220 of 1,240) with videos related to
Sort By:
Pageof 124
Science (New York, N.Y.)|November 10, 2007
The simplest double slit: interference and entanglement in double photoionization of H2D Akoury, K Kreidi, T Jahnke, et al.Oncotarget|March 28, 2018
Vive la radiorésistance!: converging research in radiobiology and biogerontology to enhance human radioresistance for deep space exploration and colonizationFranco Cortese, Dmitry Klokov, Andreyan Osipov, et al.Journal of Medicinal Chemistry|March 21, 2024
Discovery of DNL343: A Potent, Selective, and Brain-Penetrant eIF2B Activator Designed for the Treatment of Neurodegenerative DiseasesRobert A Craig, Javier De Vicente, Anthony A Estrada, et al.Nature Communications|March 19, 2026
The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced pancreatic cancer: a single-arm, phase II studyValerie Lee, Apoorvaa S Sachidanand, Christina Rodriguez, et al.Nature Communications|June 24, 2014
Ultrafast X-ray Auger probing of photoexcited molecular dynamicsB K McFarland, J P Farrell, S Miyabe, et al.Cancer Cell|October 28, 2022
Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapyKeyu Li, Joseph A Tandurella, Jessica Gai, et al.Journal of Medicinal Chemistry|December 5, 2022
Discovery of Potent and Selective Dual Leucine Zipper Kinase/Leucine Zipper-Bearing Kinase Inhibitors with Neuroprotective Properties in In Vitro and In Vivo Models of Amyotrophic Lateral SclerosisRobert A Craig, Brian M Fox, Cheng Hu, et al.Physical Review Letters|March 14, 2003
Measurement of the tensor analyzing powers T20 and T21 in elastic electron-deuteron scatteringD M Nikolenko, H Arenhövel, L M Barkov, et al.Physical Review Letters|September 3, 2013
Dynamics of hollow atom formation in intense x-ray pulses probed by partial covariance mappingL J Frasinski, V Zhaunerchyk, M Mucke, et al.Med (New York, N.Y.)|October 18, 2025
Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b/2 studyMatthew S Davids, Asher Chanan-Khan, Sikander Ailawadhi, et al.Pageof 124